|
Volumn 458, Issue 7241, 2009, Pages 976-977
|
Schizophrenia: A point of disruption
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE;
BETA CATENIN;
DISRUPTED IN SCHIZOPHRENIA 1;
DOPAMINE 2 RECEPTOR;
FLUOXETINE;
GLYCOGEN SYNTHASE KINASE 3BETA;
LITHIUM;
NEUROLEPTIC AGENT;
PHOSPHODIESTERASE IV;
PROTEIN;
PROTEIN KINASE B;
ROLIPRAM;
UNCLASSIFIED DRUG;
WNT PROTEIN;
BEHAVIOR;
BIOCHEMISTRY;
BRAIN;
CHROMOSOME;
DISEASE TREATMENT;
DRUG DEVELOPMENT;
ENZYME ACTIVITY;
GENE EXPRESSION;
MENTAL HEALTH;
NERVOUS SYSTEM DISORDER;
NEUROLOGY;
PROTEIN;
PSYCHOLOGY;
RESEARCH WORK;
TRANSLOCATION;
BIPOLAR DISORDER;
CELL MIGRATION;
DELUSION;
ENZYME ACTIVITY;
ENZYME REGULATION;
GENE CONTROL;
GENE DISRUPTION;
HALLUCINATION;
HUMAN;
MENTAL DISEASE;
NERVE CELL DIFFERENTIATION;
NERVOUS SYSTEM DEVELOPMENT;
NEURAL STEM CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
PROTEIN PROTEIN INTERACTION;
SCHIZOPHRENIA;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
ANIMALS;
BETA CATENIN;
GLYCOGEN SYNTHASE KINASE 3;
HUMANS;
MICE;
NERVE TISSUE PROTEINS;
SCHIZOPHRENIA;
SIGNAL TRANSDUCTION;
WNT1 PROTEIN;
|
EID: 65549116542
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/458976a Document Type: Short Survey |
Times cited : (10)
|
References (15)
|